Vantage Hemp Co. Engages ACOs and GPOs to Advance Participation in CMS CBD Pilot Program

Vantage Hemp Co. (“Vantage” or “the Company”), a cannabinoid manufacturer focused on pharmaceutical-grade production, announces active engagement with multiple Accountable Care Organizations (ACOs) ...
Marijuana Moment

Feds Detail Plan To Cover Up To $500 In Hemp CBD And THC Products For Medicare Patients Under Program Launching Next Week

Patients enrolled in select federal health insurance programs could have up to $500 of hemp-derived products covered each year beginning as early as April 1, according to new details about the ...

Vlasic Labs CBD Products Qualify for CMS CBD Pilot Program, Marking Historic Step for Cannabinoid Therapies

Vlasic Labs today announced that its CBD product line meets the current qualifications outlined in the Centers for Medicare & Medicaid Services (CMS) pilot program, a first-of-its-kind initiative ...
The Cannigma

Wait, Medicare Is Covering CBD? What the New Pilot Program Does (and Doesn’t) Include

The Medicare CBD coverage pilot is a CMS initiative set to launch April 1, 2026, that would allow participating healthcare organizations to furnish ...

Medicare's Cannabis (CBD) Coverage Plan Sparks Federal Controversy-Is CMS Circumventing FDA Drug Approval Standards?

WASHINGTON, DC / ACCESS Newswire / March 24, 2026 / A new federal initiative allowing up to $500 annually in hemp-derived cannabinoid products for Medicare beneficiaries is raising urgent questions ...